Industry executives: Profits drive rising prices for MS drugs
U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year. And, even though drug companies have provided no new treatment breakthroughs, the price ...
Nov 26, 2019
0
3